Cytochrome P-450 CYP3A7 Inhibitors (weak)
DBCAT004497Pharmacologic class
A DrugBank category of 3 drugs. 2 of them are approved.
- Also known as
- Weak CYP3A7 Inhibitors
What you can answer from here — as of May 20, 2021
Which targets do Cytochrome P-450 CYP3A7 Inhibitors (weak) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account